Search

Medtronic PLC

Gesloten

SectorGezondheidszorg

88.49 0.89

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

87.81

Max

88.74

Belangrijke statistieken

By Trading Economics

Inkomsten

206M

1.5B

Verkoop

-51M

9.8B

K/W

Sectorgemiddelde

21.614

47.946

EPS

1.45

Dividendrendement

3.3

Winstmarge

15.16

Werknemers

95,000

EBITDA

-682M

2B

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+17.18% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

3.30%

2.27%

Volgende Winsten

17 nov 2026

Volgende dividenddatum

16 okt 2026

Volgende Ex Dividend datum

25 dec 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-3.5B

113B

Vorige openingsprijs

87.6

Vorige sluitingsprijs

88.49

Nieuwssentiment

By Acuity

28%

72%

55 / 340 Rangschikking in Healthcare

Medtronic PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

9 okt 2026, 21:01 UTC

Medtronic PLC shares are trading modestly higher in after-market hours, following a pullback earlier in the session and three consecutive sessions of gains.

8 okt 2026, 23:05 UTC

Medtronic PLC saw a modest increase in after-market trading, recovering from earlier lows while remaining below its 20-day moving average.

7 okt 2026, 22:51 UTC

News

Medtronic PLC announced an exchange ratio of 4.5939 shares of MiniMed Group, Inc. stock for each ordinary share, contributing to a modest gain in after-market trading.

6 okt 2026, 22:40 UTC

Medtronic PLC is recovering in after-market trading, rising sharply from Tuesday's close and reaching its highest level of the day, despite remaining below its 20-day moving average.

5 okt 2026, 21:01 UTC

Medtronic PLC traded roughly flat during after-market hours, closing near the lower end of its one-month range and below its 20-day moving average.

3 okt 2026, 00:00 UTC

Medtronic PLC shares traded modestly higher in after-market hours on Friday, recovering from a brief dip and remaining near the lower end of their one-month trading range.

2 okt 2026, 23:00 UTC

Medtronic PLC is advancing in after-market trading, showing a modest increase since Friday's close, with significant upward movement shortly after the market reopened.

1 okt 2026, 22:01 UTC

News

Medtronic PLC shares are higher in after-market trading following the approval of new CPT codes for its Altaviva and Symplicity Spyral devices, effective January 2028.

30 sep 2026, 23:01 UTC

Medtronic PLC is trading modestly higher in after-market hours, reflecting broader market trends amid positive economic indicators and stronger-than-expected private sector job growth.

29 sep 2026, 20:02 UTC

Medtronic PLC shares fell sharply today, reversing a trend of higher daily closes, amid unusually high trading volume and broader market trends.

28 sep 2026, 23:16 UTC

Medtronic PLC is trading slightly lower in after-market hours, remaining below its 20-day moving average and near the lower end of its one-month range.

25 sep 2026, 23:50 UTC

Medtronic PLC is down in after-market trading, continuing a seven-session trend of lower finishes and remaining significantly below its 20-day moving average.

23 sep 2026, 20:03 UTC

News

Medtronic PLC shares fell sharply, continuing a downward trend with five consecutive losses, despite solid first-quarter results and raised full-year guidance.

22 sep 2026, 23:21 UTC

Medtronic PLC is trading modestly higher in after-market hours, stabilizing after an initial decline amid broader market weakness.

21 sep 2026, 19:46 UTC

News

Medtronic PLC shares fell as the company raised its adjusted profit forecast and reported revenue growth for Q1 fiscal 2027, despite FDA clearance for its LigaSure device.

18 sep 2026, 23:06 UTC

News

Medtronic PLC raised its fiscal 2027 profit forecast and reported first-quarter revenue of $9.756 billion, exceeding expectations, in after-market trading.

17 sep 2026, 23:06 UTC

Medtronic PLC is trading modestly higher in after-market hours, remaining near the upper end of its one-month range following Thursday's close.

16 sep 2026, 23:01 UTC

Event

Medtronic PLC's LigaSure™ RAS Maryland jaw device received FDA clearance, but the stock is modestly lower in after-market trading since Wednesday's close.

15 sep 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market hours, tracking broader market gains. No specific company news was identified to influence this movement.

14 sep 2026, 23:06 UTC

Medtronic PLC shares are lower in after-market hours amid a U.S. market decline linked to rising crude oil prices and supply concerns.

11 sep 2026, 22:52 UTC

Medtronic PLC shares are lower in after-market hours, continuing recent downward momentum and trading below the 20-day moving average.

10 sep 2026, 23:56 UTC

Medtronic PLC shares are lower in after-market hours, continuing a trend from recent sessions. Volatility marked today's trading, with no specific news identified.

9 sep 2026, 22:02 UTC

Social Media

Medtronic PLC has been recognized by Morningstar as a top dividend stock, with shares moving higher in after-market trading since Wednesday's close.

8 sep 2026, 23:01 UTC

Medtronic PLC shares are trading higher in after-market hours, reflecting notable fluctuations during the session and remaining near the upper end of their one-month range.

4 sep 2026, 23:16 UTC

Shares of Medtronic PLC are higher in after-market hours, despite earlier declines. The stock remains above its 20-day moving average.

3 sep 2026, 23:01 UTC

Medtronic PLC shares declined in after-market trading, reversing gains from earlier sessions. No specific news was identified to explain the price movement.

2 sep 2026, 23:06 UTC

Medtronic PLC shares are trading higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month trading range.

1 sep 2026, 23:06 UTC

Medtronic PLC shares declined during after-market hours, showing notable volatility. The price remains above its 20-day moving average and near the one-month range's upper end.

31 aug 2026, 23:01 UTC

Medtronic PLC shares are higher in after-market trading, positioned about 1.01% above their 20-day moving average. No specific news was identified for the movement.

29 aug 2026, 00:06 UTC

Medtronic PLC shares advanced in after-market trading, fluctuating amid broader market expectations for interest rate hikes and ongoing inflation concerns.

Peer Vergelijking

Prijswijziging

Medtronic PLC Prognose

Koersdoel

By TipRanks

17.18% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 102.824 USD  17.18%

Hoogste 118 USD

Laagste 85 USD

Gebaseerd op 19 Wall Street-analisten die 12-maands prijsdoelen bieden voor Medtronic PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

19 ratings

10

Buy

9

Hold

0

Sell

Sentiment

By Acuity

55 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.